(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Knockdown of ß4GalT5 results in dorsalization.
(A) Lateral views of 2-somite control-injected and
ß4GalT5MO-injected embryos. The morphant phenotype is manifested by an
elongation of the anteroposterior axis. (B) 26-somite embryo injected
with control morpholinos, lateral view. (C) When
ß4GalT5MO-injected embryos reach the 26-somite stage, the mature
ß4GalT5MO phenotype is observed (lateral and dorsal views). (Class 3) 5
ng of ß4GalT5 morpholino results in mild dorsalization manifested by a
slight tail coil. This phenotype is similar to the pgy phenotype
reported by Mullins et al. (Mullins et
al., 1996) and correlates with their Class 3. (Class 4) 10 ng of
morpholino produces a more significant coiling of the tail, as well as
dorsalization within the anterior regions of the embryo, and embryos are
considered moderately dorsalized, similar to the snh phenotype
representing Class 4 of Mullins et al.
(Mullins et al., 1996). (Class
5) Injection of 15-20 ng of ß4GalT5 morpholino produces the most severe
dorsalization, which appears similar to that seen in the swr mutant.
(D) Lateral view of 26-somite embryo injected with ß4GalT5MO3 and
mRNA encoding full-length ß4GalT5. These embryos were essentially wild
type in appearance. (E) In situ hybridization of pax2a in the
otic vesicle of 26-somite control embryo; asterisks indicate the paired
otoliths, which are absent in an equivalently staged ß4GalT5MO
embryo.